<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "basiliximab inj VIAL">
<dose><value>20</value>
<value>10</value>
<value>12</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>20 mg</value>
</strength>
<frequency><value>ONCE</value>
</frequency>
<instruction><value>Administer within 2 hours pre-transplant in operating room (day zero)</value>
<value>Administer 1 dose on day 4 post-transplant.</value>
<value>Administer 1 dose on day 4 post-transplant. Hold dose if complications occur.</value>
<value>INITIAL DOSE: Administer within 6 hours of organ perfusion.</value>
<value>SECOND DOSE: Administer 1 dose on Day 4 post-transplant. Hold dose if complications occur.</value>
<value>THIRD DOSE: Administer 1 dose between Day 8 and Day 10 post-transplant IF ascites fluid loss exceeds 70 mL/kg or is more than 5 L.</value>
<value>Administer immediately prior to cardiopulmonary bypass started or within 6 hours of organ perfursion.</value>
<value>Administer within 2 hours pre-transplant in operating room (day zero). MAXIMUM dose = 20 mg.</value>
<value>Administer 1 dose on day 4 post-transplant. MAXIMUM dose = 20 mg.</value>
</instruction>
<volume></volume>
<units><value>mg</value>
<value>mg/m2</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Renal Transplant - Infants/Children &amp;lt; 35 kg</value>
<value>Renal Transplant - Infants/Children &amp;gt; 35 kg</value>
<value>Liver Transplant - Infants/Children &amp;lt;35 kg.</value>
<value>Liver Transplant - Infants/Children &amp;gt;35 kg.</value>
<value>Heart Transplant - Infants/Children &amp;lt; 35 kg</value>
<value>Heart Transplant - Infants/Children &amp;gt; 35 kg</value>
<value>Children: 2 to 15 years of age</value>
</AdditionalNotes>
<BackgroundInformation><value>Specialized High Cost Drug List</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus></AHSFormularyStatus>
<HighAlert></HighAlert>
</drug>